technetium tc 99m sestamibi has been researched along with Diabetic Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acampa, W; Assante, R; Cantoni, V; Cuocolo, A; Daniele, S; Evangelista, L; Fiumara, G; Nappi, C; Petretta, M; Zampella, E | 1 |
| Ahmadabadi, MN; Assadi, M; Hedayat, DK; Mohagheghie, A; Pourbehi, MR | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Reclassification of cardiovascular risk by myocardial perfusion imaging in diabetic patients with abnormal resting electrocardiogram.
Topics: Aged; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Cardiomyopathies; Female; Follow-Up Studies; Heart Ventricles; Humans; Italy; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Risk Factors; Stress, Physiological; Stroke Volume; Technetium Tc 99m Sestamibi; Ventricular Dysfunction, Left | 2014 |
Myocardial perfusion imaging using technetium-99m sestamibi in asymptomatic diabetic patients.
Topics: Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2011 |